课题基金 / 基金详情

TRPV4, a Ca ion channel plays pivotal role in chondrogenic mechanotransduction in ATDC5

TRPV4, a Ca ion channel plays pivotal role in chondrogenic mechanotransduction in ATDC5
TRPV4,一种 Ca 离子通道,在 ATDC5 的软骨形成机械转导中发挥关键作用
批准号:
24659671
负责人:
ISHIGURO Naoki
金额:
$2.33万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Challenging Exploratory Research
财政年份:
2012
资助国家:
日本
项目状态:
已结题
起止时间:
2012-04-01 至 2014-03-31

项目摘要

项目成果

ISHIGURO Naoki的其他基金

相似基金

相关文献

中文摘要
翻译
众所周知,软骨细胞的代谢活动部分受物理因素的调节。然而,在软骨细胞中负责感知和转导的特定细胞机械传感器尚未完全确定。已有报道TRPV4激活可通过SOX9途径参与软骨形成过程。在这项研究中,我们证明了TRPV4作为一种机械受体在软骨细胞中响应机械应力,并确定了导致软骨形成的细胞内机制。我们的结论是,机械应力促进ATDC5细胞软骨形成,增加SOX9 mRNA的表达。化学和siRNA抑制TRPV4抑制ATDC5细胞机械应力的软骨形成作用。补充RR和转染TRPV4 siRNA可抑制机械应力引起的Ca内流。
英文摘要
It is well known that chondrocyte metabolic activity is partly regulated by physical factors.However, the specific cellular mechanosensor responsible for perception and transduction has not been fully identified in chondrocytes. It has already reported that TRPV4 activation can contribute to the process of chondrogenesis via SOX9 pathway.In this study we demonstrated that TRPV4 works as a mechanoreceptor in response to mechanical stress in chondrocytes, and to determine the intracellular mechanisms leading to the chondorogensis. Our conclusions are as follow, Mechanical stress promoted chondorogensis in ATDC5 cells with increasing mRNA expression of SOX9. Inhibition of TRPV4 by chmical and siRNA suppressed chondrogenesis effect of mechanical stress in ATDC5 cells. Ca influx by mechanical stress was suppressed by RR supplementation and TRPV4 siRNA transfection.
期刊论文(58)
专著(0)
科研奖励(0)
会议论文
Prognostic factors for trochanteric overgrowth after containment treatment in Legg-Calvé-Perthes disease.
Legg-Calvé-Perthes 病遏制治疗后转子过度生长的预后因素。
DOI: 10.1097/bpb.0b013e32835f585b
发表时间: 2013
期刊: J Pediatr Orthop B
影响因子: 1.1
作者: [Kitoh H, Kaneko H, Mishima K, Matsushita M, Ishiguro N]
通讯作者: Ishiguro N
MPFL再建+脛骨粗面移行術後の膝蓋骨高に関するX線学的検討ー治療成績評価における各種計測法の違いー
MPFL重建+胫骨粗隆过渡后髌骨高度X线检查 - 各种测量方法评估治疗效果的差异 -
DOI: --
发表时间: 2012
期刊: JOSKAS
影响因子: --
作者: [酒井忠博, 平岩秀樹, 濱田恭, 山本隆一郎, 大間知孝顕, 松川哲也, 大野洋平, 中島基成, 石塚真哉, 石黒直樹]
通讯作者: 石黒直樹
DOI: 10.1002/ajmg.a.36134
发表时间: 2013-10-01
期刊: AMERICAN JOURNAL OF MEDICAL GENETICS PART A
影响因子: 2
作者: [Matsushita, Masaki, Kitoh, Hiroshi, Nishimura, Gen]
通讯作者: Nishimura, Gen
Novel compound heterozygous mutations in the cathepsin K gene in Japanese female siblings with pyknodysostosis
患有致密性骨性骨质疏松症的日本女性同胞中组织蛋白酶 K 基因的新型复合杂合突变
DOI: 10.1159/000336581
发表时间: 2012
期刊: Mol Syndromol
影响因子: 1.1
作者: [Matsushita M, Kitoh H, Kaneko H, Mishima K, Itoh Y, Hattori T, Ishiguro N]
通讯作者: Ishiguro N
共 50 条
    Development of a new therapeutic drug for osteoarthritis that has a cartilage-protecting effect by inhibiting Wnt/ADAM10
    • 批准号:
      19H03779
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.98万
    • 财政年份:
      2019
    • 负责人:
      ISHIGURO Naoki
    • 依托单位:
    The research of the drugs that can promote SOX9m RNA expression in chondrocyte
    • 批准号:
      22659269
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $1.98万
    • 财政年份:
      2010
    • 负责人:
      ISHIGURO Naoki
    • 依托单位:
    The Research of the bioreactor that can promote the cell differentiation from bone marrow stem cells to osteogenic cells
    • 批准号:
      21390419
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.57万
    • 财政年份:
      2009
    • 负责人:
      ISHIGURO Naoki
    • 依托单位:
    The development of tissue engineering procedure for osteogensesis -investigation using plate rich plasma and mesenchymal stem cell-
    • 批准号:
      17390416
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.63万
    • 财政年份:
      2005
    • 负责人:
      ISHIGURO Naoki
    • 依托单位:
    国内基金
    海外基金
    胆管细胞 USP28 去泛素化调控 SOX9 影响胆汁淤积性肝病的机制研究
    • 批准号:
      ZCLMS26H0301
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      蔡昌洲
    • 依托单位:
    乌梅丸调控CAFs分泌IL6+外泌体介导的SOX9信号通路抑制结直肠癌干性与转移的分子机制研究
    • 批准号:
      JCZRQNB202600638
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    O-GlcNAc糖基化通过稳定SOX9促进子宫内膜癌恶性进展的分子机制研究
    • 批准号:
      2026JJ60082
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      张娜
    • 依托单位:
    RUNX2/SOX9表达比值调控骨折愈合细胞命运决定的分子开关机制研究
    • 批准号:
      2026JJ82203
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      贺啊萍
    • 依托单位: